AHR and pancreatic adenocarcinoma: While there is a lack of direct experimental data on the effects of indole derivatives in pancreatic adenocarcinoma, one study demonstrates that selective AHR modulators, such as omeprazole and tranilast, can effectively modulate the invasive behavior of pancreatic adenocarcinoma cells [93].